The role of pathologists in recognition of morphologic and biologic features of genetically mutated breast cancer.

doi:10.1111/tbj.14012

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Back to search

Article

The role of pathologists in recognition of morphologic and biologic features of genetically mutated breast cancer.

The breast journal - 1 Aug 2020

Masood Shahla

Abstract excerpt

The recent introduction of genomic medicine and emphasis on optimizing breast cancer risk reduction mortalities has provided opportunities for pathologists to partner with clinicians in advancing the diagnosis and management of breast cancer patients. The discovery of breast cancer genes BRCA1, BRCA2, and other breast cancer genes is considered a major breakthrough in the understanding of hereditary breast...

Topics

BRCA1 Protein
BRCA2 Protein
Biological Products
Breast
Breast Neoplasms
Female
Genes, BRCA2
Genetic Predisposition to Disease
Humans
Mutation
Pathologists

Source

Open in PubMed

Identifiers

PMID: 32845077
DOI: 10.1111/tbj.14012

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 30 Aug 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

discussions

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics